![PDF) The anti-IgE monoclonal antibody omalizumab as adjuvant treatment in desensitization to carboplatin in patients with ovarian cancer PDF) The anti-IgE monoclonal antibody omalizumab as adjuvant treatment in desensitization to carboplatin in patients with ovarian cancer](https://i1.rgstatic.net/publication/355277600_The_anti-IgE_monoclonal_antibody_omalizumab_as_adjuvant_treatment_in_desensitization_to_carboplatin_in_patients_with_ovarian_cancer/links/61c1fc7e8bb2010184293f70/largepreview.png)
PDF) The anti-IgE monoclonal antibody omalizumab as adjuvant treatment in desensitization to carboplatin in patients with ovarian cancer
Bibliometric analysis of hotspots and frontiers in cancer-related fatigue among ovarian cancer survivors | PLOS ONE
![Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium | British Journal of Cancer Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.bjc.6604820/MediaObjects/41416_2009_Article_BF6604820_Fig1_HTML.jpg)
Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium | British Journal of Cancer
![Cancers | Free Full-Text | Worldwide Burden, Risk Factors, and Temporal Trends of Ovarian Cancer: A Global Study Cancers | Free Full-Text | Worldwide Burden, Risk Factors, and Temporal Trends of Ovarian Cancer: A Global Study](https://pub.mdpi-res.com/cancers/cancers-14-02230/article_deploy/html/images/cancers-14-02230-g001.png?1651801402)
Cancers | Free Full-Text | Worldwide Burden, Risk Factors, and Temporal Trends of Ovarian Cancer: A Global Study
![Frontiers | Identification of NAD+ Metabolism-Derived Gene Signatures in Ovarian Cancer Prognosis and Immunotherapy Frontiers | Identification of NAD+ Metabolism-Derived Gene Signatures in Ovarian Cancer Prognosis and Immunotherapy](https://www.frontiersin.org/files/Articles/905238/fgene-13-905238-HTML/image_m/fgene-13-905238-g003.jpg)
Frontiers | Identification of NAD+ Metabolism-Derived Gene Signatures in Ovarian Cancer Prognosis and Immunotherapy
![Blood bioactive sphingolipids in patients with advanced serous epithelial ovarian cancer – mass spectrometry analysis Blood bioactive sphingolipids in patients with advanced serous epithelial ovarian cancer – mass spectrometry analysis](https://www.archivesofmedicalscience.com/f/pictures/80153_f5e2c.jpg)
Blood bioactive sphingolipids in patients with advanced serous epithelial ovarian cancer – mass spectrometry analysis
![Exploiting epigenetic dependencies in ovarian cancer therapy - Coughlan - 2021 - International Journal of Cancer - Wiley Online Library Exploiting epigenetic dependencies in ovarian cancer therapy - Coughlan - 2021 - International Journal of Cancer - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/be3c8e27-80a4-46b6-a4cd-2c9244979745/ijc33727-fig-0001-m.jpg)
Exploiting epigenetic dependencies in ovarian cancer therapy - Coughlan - 2021 - International Journal of Cancer - Wiley Online Library
![An epidemiologic risk prediction model for ovarian cancer in Europe: the EPIC study | British Journal of Cancer An epidemiologic risk prediction model for ovarian cancer in Europe: the EPIC study | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fbjc.2015.22/MediaObjects/41416_2015_Article_BFbjc201522_Fig1_HTML.jpg)
An epidemiologic risk prediction model for ovarian cancer in Europe: the EPIC study | British Journal of Cancer
![Biomedicines | Free Full-Text | The Role of the Adipokine Resistin in the Pathogenesis and Progression of Epithelial Ovarian Cancer Biomedicines | Free Full-Text | The Role of the Adipokine Resistin in the Pathogenesis and Progression of Epithelial Ovarian Cancer](https://www.mdpi.com/biomedicines/biomedicines-10-00920/article_deploy/html/images/biomedicines-10-00920-g001-550.jpg)
Biomedicines | Free Full-Text | The Role of the Adipokine Resistin in the Pathogenesis and Progression of Epithelial Ovarian Cancer
![Cells | Free Full-Text | Hereditary Ovarian Carcinoma: Cancer Pathogenesis Looking beyond BRCA1 and BRCA2 Cells | Free Full-Text | Hereditary Ovarian Carcinoma: Cancer Pathogenesis Looking beyond BRCA1 and BRCA2](https://www.mdpi.com/cells/cells-11-00539/article_deploy/html/images/cells-11-00539-g001.png)
Cells | Free Full-Text | Hereditary Ovarian Carcinoma: Cancer Pathogenesis Looking beyond BRCA1 and BRCA2
![Pharmaceutics | Free Full-Text | Potential Role of Vaginal Microbiota in Ovarian Cancer Carcinogenesis, Progression and Treatment Pharmaceutics | Free Full-Text | Potential Role of Vaginal Microbiota in Ovarian Cancer Carcinogenesis, Progression and Treatment](https://pub.mdpi-res.com/pharmaceutics/pharmaceutics-15-00948/article_deploy/html/images/pharmaceutics-15-00948-g001-550.jpg?1678857036)
Pharmaceutics | Free Full-Text | Potential Role of Vaginal Microbiota in Ovarian Cancer Carcinogenesis, Progression and Treatment
![Statin use and survival among women with ovarian cancer: an Australian national data-linkage study | British Journal of Cancer Statin use and survival among women with ovarian cancer: an Australian national data-linkage study | British Journal of Cancer](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41416-021-01460-4/MediaObjects/41416_2021_1460_Fig1_HTML.png)
Statin use and survival among women with ovarian cancer: an Australian national data-linkage study | British Journal of Cancer
![Medicina | Free Full-Text | Progression Free Survival, Overall Survival, and Relapse Rate in Endometrioid Ovarian Cancer and Synchronous Endometrial- Ovarian Endometrioid Cancer (SEO-EC): Results from a Large Retrospective Analysis Medicina | Free Full-Text | Progression Free Survival, Overall Survival, and Relapse Rate in Endometrioid Ovarian Cancer and Synchronous Endometrial- Ovarian Endometrioid Cancer (SEO-EC): Results from a Large Retrospective Analysis](https://pub.mdpi-res.com/medicina/medicina-58-01706/article_deploy/html/images/medicina-58-01706-g001.png?1669177358)
Medicina | Free Full-Text | Progression Free Survival, Overall Survival, and Relapse Rate in Endometrioid Ovarian Cancer and Synchronous Endometrial- Ovarian Endometrioid Cancer (SEO-EC): Results from a Large Retrospective Analysis
Bibliometric analysis of hotspots and frontiers in cancer-related fatigue among ovarian cancer survivors | PLOS ONE
![Ovarian Cancer Immunotherapy en Route: IL9 Inhibits Growth of Ovarian Cancer and Upregulates its Expression of Ox40L and 4-1BBL Ovarian Cancer Immunotherapy en Route: IL9 Inhibits Growth of Ovarian Cancer and Upregulates its Expression of Ox40L and 4-1BBL](https://article.imrpress.com/journal/EJGO/43/2/10.31083/j.ejgo4302021/2709-0086-43-2-163/fig1.jpg)
Ovarian Cancer Immunotherapy en Route: IL9 Inhibits Growth of Ovarian Cancer and Upregulates its Expression of Ox40L and 4-1BBL
![Frontiers | Association Between Benign Ovarian Tumors and Ovarian Cancer Risk: A Meta-Analysis of Ten Epidemiological Studies Frontiers | Association Between Benign Ovarian Tumors and Ovarian Cancer Risk: A Meta-Analysis of Ten Epidemiological Studies](https://www.frontiersin.org/files/Articles/895618/fonc-12-895618-HTML/image_m/fonc-12-895618-g001.jpg)
Frontiers | Association Between Benign Ovarian Tumors and Ovarian Cancer Risk: A Meta-Analysis of Ten Epidemiological Studies
![IJMS | Free Full-Text | Strategy for Pre-Clinical Development of Active Targeting MicroRNA Oligonucleotide Therapeutics for Unmet Medical Needs IJMS | Free Full-Text | Strategy for Pre-Clinical Development of Active Targeting MicroRNA Oligonucleotide Therapeutics for Unmet Medical Needs](https://www.mdpi.com/ijms/ijms-24-07126/article_deploy/html/images/ijms-24-07126-g001.png)
IJMS | Free Full-Text | Strategy for Pre-Clinical Development of Active Targeting MicroRNA Oligonucleotide Therapeutics for Unmet Medical Needs
![A machine learning approach to identify predictive molecular markers for cisplatin chemosensitivity following surgical resection in ovarian cancer | Scientific Reports A machine learning approach to identify predictive molecular markers for cisplatin chemosensitivity following surgical resection in ovarian cancer | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-96072-6/MediaObjects/41598_2021_96072_Fig1_HTML.png)
A machine learning approach to identify predictive molecular markers for cisplatin chemosensitivity following surgical resection in ovarian cancer | Scientific Reports
![Frontiers | Pre-diagnosis Cruciferous Vegetables and Isothiocyanates Intake and Ovarian Cancer Survival: A Prospective Cohort Study Frontiers | Pre-diagnosis Cruciferous Vegetables and Isothiocyanates Intake and Ovarian Cancer Survival: A Prospective Cohort Study](https://www.frontiersin.org/files/Articles/778031/fnut-08-778031-HTML/image_m/fnut-08-778031-g001.jpg)
Frontiers | Pre-diagnosis Cruciferous Vegetables and Isothiocyanates Intake and Ovarian Cancer Survival: A Prospective Cohort Study
![Lassa-VSV chimeric virus targets and destroys human and mouse ovarian cancer by direct oncolytic action and by initiating an anti-tumor response - ScienceDirect Lassa-VSV chimeric virus targets and destroys human and mouse ovarian cancer by direct oncolytic action and by initiating an anti-tumor response - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0042682220302117-gr3.jpg)
Lassa-VSV chimeric virus targets and destroys human and mouse ovarian cancer by direct oncolytic action and by initiating an anti-tumor response - ScienceDirect
![Shifting incidence and survival of epithelial ovarian cancer (1995‐2014): A SurvMark‐2 study - Cabasag - 2023 - International Journal of Cancer - Wiley Online Library Shifting incidence and survival of epithelial ovarian cancer (1995‐2014): A SurvMark‐2 study - Cabasag - 2023 - International Journal of Cancer - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/fbd97a7f-5f11-48df-b512-7997fe44f6ed/ijc34403-toc-0001-m.png)